PCI Biotech Holding ASA (PCIB) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.501x

Based on the latest financial reports, PCI Biotech Holding ASA (PCIB) has a cash flow conversion efficiency ratio of -0.501x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr-6.26 Million ≈ $-659.15K USD) by net assets (Nkr12.52 Million ≈ $1.32 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of PCI Biotech Holding ASA for the company's overall valuation and market capitalisation.

PCI Biotech Holding ASA - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how PCI Biotech Holding ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

PCI Biotech Holding ASA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PCI Biotech Holding ASA ranked by their cash flow conversion efficiency. Explore PCI Biotech Holding ASA cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Ming Le Sports AG F:ML2	-0.018x
Sejahtera Bintang Abadi Textile Tbk JK:SBAT	-0.023x
Sino-German United AG F:SGU	N/A
Lytus Technologies Holdings PTV. Ltd. Common Shares NASDAQ:LYT	0.005x
Virpax Pharmaceuticals Inc NASDAQ:VRPX	3.142x
HARVEST MINERALS LTD F:7HM	N/A
Baltic Bridge S.A. WAR:WIS	N/A
M Winkworth PLC LSE:WINK	0.190x

Annual Cash Flow Conversion Efficiency for PCI Biotech Holding ASA (2008–2024)

The table below shows the annual cash flow conversion efficiency of PCI Biotech Holding ASA from 2008 to 2024. View PCI Biotech Holding ASA (PCIB) stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Nkr23.45 Million ≈ $2.47 Million	Nkr-13.76 Million ≈ $-1.45 Million	-0.587x	-53.00%
2023-12-31	Nkr39.04 Million ≈ $4.11 Million	Nkr-14.97 Million ≈ $-1.58 Million	-0.383x	+62.72%
2022-12-31	Nkr57.40 Million ≈ $6.04 Million	Nkr-59.04 Million ≈ $-6.21 Million	-1.029x	-71.35%
2021-12-31	Nkr113.79 Million ≈ $11.97 Million	Nkr-68.31 Million ≈ $-7.19 Million	-0.600x	-46.79%
2020-12-31	Nkr189.24 Million ≈ $19.91 Million	Nkr-77.39 Million ≈ $-8.14 Million	-0.409x	-24.85%
2019-12-31	Nkr254.83 Million ≈ $26.82 Million	Nkr-83.47 Million ≈ $-8.78 Million	-0.328x	-258.30%
2018-12-31	Nkr339.95 Million ≈ $35.77 Million	Nkr-31.08 Million ≈ $-3.27 Million	-0.091x	+87.51%
2017-12-31	Nkr41.84 Million ≈ $4.40 Million	Nkr-30.62 Million ≈ $-3.22 Million	-0.732x	+73.17%
2016-12-31	Nkr13.09 Million ≈ $1.38 Million	Nkr-35.69 Million ≈ $-3.76 Million	-2.728x	-267.80%
2015-12-31	Nkr44.28 Million ≈ $4.66 Million	Nkr-32.84 Million ≈ $-3.46 Million	-0.742x	+78.66%
2014-12-31	Nkr9.11 Million ≈ $959.06K	Nkr-31.67 Million ≈ $-3.33 Million	-3.475x	-427.45%
2013-12-31	Nkr43.40 Million ≈ $4.57 Million	Nkr-28.59 Million ≈ $-3.01 Million	-0.659x	-88.59%
2012-12-31	Nkr69.71 Million ≈ $7.34 Million	Nkr-24.35 Million ≈ $-2.56 Million	-0.349x	-69.72%
2011-12-31	Nkr92.53 Million ≈ $9.74 Million	Nkr-19.05 Million ≈ $-2.00 Million	-0.206x	-104.92%
2010-12-31	Nkr105.42 Million ≈ $11.09 Million	Nkr-10.59 Million ≈ $-1.11 Million	-0.100x	+79.07%
2009-12-31	Nkr35.08 Million ≈ $3.69 Million	Nkr-16.84 Million ≈ $-1.77 Million	-0.480x	-151.50%
2008-12-31	Nkr49.30 Million ≈ $5.19 Million	Nkr-9.41 Million ≈ $-990.10K	-0.191x	--

About PCI Biotech Holding ASA

OL:PCIB Norway Biotechnology

Market Cap

$274.95K

Nkr2.61 Million NOK

Market Cap Rank

#31252 Global

#275 in Norway

Share Price

Nkr0.07

Change (1 day)

-39.13%

52-Week Range

Nkr0.07 - Nkr0.47

All Time High

Nkr86.30